Antibody Drug Offers Hope in Cancer Treatment

An antibody drug in development has been shown in mice studies to attack and kill virtually every type of cancer.  The drug blocks the production of a protein, CD47, produced in large amounts in cancer cells.  Blocking the production of this protein allows the immune system to more effectively fight and destroy cancer cells.  Researchers are hopeful […]

High-Protein Diets and Cancer

Among the fad diets that have gained popularity in recent years have been those focusing on a high-protein, low carbohydrate approach.  The weight-loss effects of such diets (such as the Atkins Diet) certainly have been shown, but what are the long-term effects of such diets?  In my forthcoming book, The Layman’s Guide to Surviving Cancer, […]

Mammography Controversy Continues

The debate over the efficacy of routine mammography screening to detect cancer continues to rage.  A recent follow-up study from Canada suggests that such routine screening does not help detect or prevent the advance of breast cancer, while other researchers point out the weaknesses in the Canadian study and urge continued screening.  Check it out […]

Chronic Lymphocytic Leukemia Treatment

Researchers in New York have determined that a combination of rituximab and idelalisib is effective in limiting the progression of chronic lymphocytic leukemia (CLL).  In fact, the positive effects shown in this study were so compelling that the study was halted and the treatment was prescribed for all of the patients in the study.  The combination of drugs […]

Lung Cancer Drug Setback

Unfortunately, Pfizer announced that its drug for late stage lung cancer treatment, Dacomitnib, failed in two late-stage studies.  Another stage is set to be reported in 2015.  See the report on this development at http://finance.yahoo.com/news/pfizer-cancer-drug-fails-2-133921000.html.